Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADPH-dependent enzymes represent a large and functionally diverse class of enzymes that use NADPH as a coenzyme or electron donor for metabolic, biosynthetic, and detoxification reactions. This group includes oxidoreductases (such as NADPH oxidases), dehydrogenases, monooxygenases, and kinases, each contributing to fundamental cellular functions ranging from redox maintenance and anabolic synthesis to immune defense. Individual NADPH-dependent enzymes are implicated in disease processes including cancer, inflammation, cardiovascular and metabolic disorders, making select members important drug targets. However, the term "NADPH-dependent enzymes" is an umbrella label and not a suitable representation of a unique, actionable molecular target for drug development.
Inhibition of electron transfer to oxygen (NOX inhibitors); Modulation of biosynthetic redox reactions; Blockade of ROS generation
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADPH-dependent enzymes.